Qilian International Holding Group (Qilian International Holding Group) Interest Expense : $0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Qilian International Holding Group Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Qilian International Holding Group's interest expense for the six months ended in Sep. 2023 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Qilian International Holding Group's Operating Income for the six months ended in Sep. 2023 was $ -2.73 Mil. Qilian International Holding Group's Interest Expense for the six months ended in Sep. 2023 was $ 0.00 Mil. GuruFocus does not calculate Qilian International Holding Group's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Qilian International Holding Group Interest Expense Historical Data

The historical data trend for Qilian International Holding Group's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qilian International Holding Group Interest Expense Chart

Qilian International Holding Group Annual Data

Trend

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Interest Expense

Get a 7-Day Free Trial

-0.22

-0.24

-0.06

Qilian International Holding Group Semi-Annual Data
	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Interest Expense	Get a 7-Day Free Trial								0.02	-	-	-	-

Qilian International Holding Group Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

Qilian International Holding Group (NAS:QLI) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Qilian International Holding Group's Interest Expense for the six months ended in Sep. 2023 was $0.00 Mil. Its Operating Income for the six months ended in Sep. 2023 was $-2.73 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Sep. 2023 was $0.03 Mil.

Qilian International Holding Group's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

GuruFocus does not calculate Qilian International Holding Group's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Qilian International Holding Group Ltd has enough cash to cover all of its debt. Its financial situation is stable.

Qilian International Holding Group (Qilian International Holding Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qilian International Holding Group Ltd (NAS:QLI) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jiuquan Economic and Technological Development Zone, Gansu Province, Jiuquan, CHN, 735000

Website

http://ir.qlsyy.net

Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.